Back to ALKEON CAPITAL MANAGEMENT LLC ALKEON CAPITAL MANAGEMENT LLC

KROSKROS
23 quarters

Position history for ALKEON CAPITAL MANAGEMENT LLCALKEON CAPITAL MANAGEMENT LLC's holdings in KEROS THERAPEUTICS INC

ALKEON CAPITAL MANAGEMENT LLC previously held 0 shares of KROS (KEROS THERAPEUTICS INC), worth $0 as of 2025-Q4.

Final Value

$0

Final Shares

0

Total Value Change

-$1.1M

Total Shares Change

-30,000

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Exited
0
-100.0%
$00.0%$20.27
0
2025-Q3
Unchanged
850,511
0.0%
$13.5M0.0%$15.95
0
2025-Q2
Unchanged
850,511
0.0%
$11.4M0.0%$13.49
0
2025-Q1
Decreased
850,511
-22.8%
$8.7M0.0%$10.79
0
2024-Q4
Decreased
1.1M
-42.0%
$17.4M0.0%$15.64
0
2024-Q3
Increased
1.9M
+18.7%
$110.2M0.2%$56.45
42
2024-Q2
Unchanged
1.6M
0.0%
$73.1M0.1%$45.70
0
2024-Q1
Increased
1.6M
+6.7%
$105.8M0.2%$66.20
38
2023-Q4
Decreased
1.5M
-10.6%
$59.6M0.1%$39.76
0
2023-Q3
Unchanged
1.7M
0.0%
$53.4M0.1%$31.88
0
2023-Q2
Decreased
1.7M
-0.1%
$67.4M0.1%$39.87
0
2023-Q1
Increased
1.7M
+20.5%
$71.7M0.2%$42.13
42
2022-Q4
Increased
1.4M
+15.2%
$66.9M0.3%$48.02
41
2022-Q3
Increased
1.2M
+2.8%
$45.5M0.1%$36.31
36
2022-Q2
Increased
1.2M
+29.8%
$32.5M0.1%$27.18
36
2022-Q1
Decreased
906,433
-2.2%
$49.3M0.1%$53.66
0
2021-Q4
Increased
926,433
+32.1%
$54.2M0.1%$56.30
45
2021-Q3
Decreased
701,433
-0.3%
$27.7M0.0%$41.11
0
2021-Q2
Increased
703,439
+34.4%
$29.9M0.0%$42.40
37
2021-Q1
Increased
523,439
+0.3%
$32.2M0.0%$57.55
29
2020-Q4
Increased
522,121
+1640.4%
$36.8M0.1%$72.08
47
2020-Q3
Unchanged
30,000
0.0%
$1.2M0.0%$39.38
0
2020-Q2
New
30,000
-
$1.1M0.0%$38.00
35

Other major holders of KROS: BlackRock Finance, Inc., RA CAPITAL MANAGEMENT, L.P., VANGUARD GROUP INC, STATE STREET CORP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used